REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/06/2026
Back to search
Official data from USPTO
IMPACT IMPROVING PATIENT ACCESS TO CLINICAL TRIALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
IMPACT IMPROVING PATIENT ACCESS TO CLINICAL TRIALS
ST13
US500000086863341Class
36, 41
Filing
86863341
Registration
5219362
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
06/07/2026
Trademark type
Word
Nice classes
36, 41
Filing date
12/31/2015
Registration date
06/06/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/03/2024
Last transaction
06/07/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/10/2016
First use in commerce
01/10/2016
Drawing code
4
Owner type
03
Owner location
Danville, CA, US
Examiner
JOINER, KATINA JACKSON
Current location
Historical data usage
Holders and representatives
Holders
L. F. (pessoa física)
Representatives
Jean L. Batman LEGAL VENTURE COUNSEL, INC.
Technical classification
Nice Classes
Class 36Class 41
Vienna Codes
No Vienna codes available.
Goods and services
Class 36
Accepting and administering monetary charitable contributions; Charitable foundation servicesproviding financial assistance for programs and services of others; Charitable foundation servicesproviding financial support to cancer patients for participation in clinical trials; Charitable foundation servicesproviding fundraising activities to support medical research and procedures for those in need; Charitable foundation servicesproviding fundraising activitiesfundingscholarships and/or financial assistance for cancer patient participation in clinical trials; Charitable fundraising; Charitable fundraising services by means of running and walking events; Charitable fundraising services by means of an entertainment event; Charitable servicesgranting funds to schools
Class 41
Charitable servicesmentoring of cancer patients in the field of clinical trials; Charitable servicesproviding educational materials in the nature of websitesbrochureshandoutsadvertising regarding clinical trials availability and admission criteria to cancer patients; Development and dissemination of printed educational materials of others in the field of cancer treatmentclinical trialsearly detection of cancer; Educational servicesconducting community outreach in the form of one-on-one counselingworkshopsevents for cancer patients in the fields of cancer treatmentclinical trialsearly detection of cancer; Educational servicesseminars and online programs providing data about cancer treatment and clinical trials and distribution of educational materials in connection therewith; Providing educational assessment services; Providing science educational mentoring services and programs
Publications
History of USPTO decisions and trademark events.
32 publications found
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
06/03/2024
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06/03/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/03/2024
E815
TEAS SECTION 8 & 15 RECEIVED
11/28/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/06/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
06/06/2017
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/03/2017
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/02/2017
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/05/2017
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/26/2017
IUAF
USE AMENDMENT FILED
03/16/2017
EISU
TEAS STATEMENT OF USE RECEIVED
03/16/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/16/2017
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/20/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/25/2016
PUBO
PUBLISHED FOR OPPOSITION
10/25/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/05/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/15/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
09/15/2016
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/15/2016
GNEA
EXAMINERS AMENDMENT E-MAILED
09/15/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/15/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/13/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/12/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/12/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/27/2016
GNRT
NON-FINAL ACTION E-MAILED
04/27/2016
CNRT
NON-FINAL ACTION WRITTEN
04/27/2016
DOCK
ASSIGNED TO EXAMINER
04/16/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/12/2016
NWAP
NEW APPLICATION ENTERED
01/04/2016
Continuous trademark protection
Get notified about every new filing that threatens IMPACT IMPROVING PATIENT ACCESS TO CLINICAL TRIALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.